Expression quantitative trait loci (eQTLs) are context dependent, and therefore change 12 between tissues, cell types, and after cell treatment. In addition, SNP positions and RNAseq counts 13 must be updated after assembly of new reference genome sequences. Therefore, we remapped 14 eQTLs with Matrix eQTL using the previously generated and publicly available data from four 15 contexts of peripheral blood mononuclear cells (PBMCs) from European Warmblood horses to the 16 EquCab3.0 reference genome, and used a linear mixed model in R to identify eQTLs with 17 significantly different gene expression regulation in treated PBMCs when compared to no treatment 18 (baseline). We found no evidence that SNPs associated with significant changes in gene expression 19 between MCK and a treatment in PBMCs caused strong opposing regulatory effects. We identified 20 canonical pathways with a significant number of genes in PBMCs with altered gene expression 21 regulation when treated with lipopolysaccharides (LPS) and hay-dust extract (HDE). Significant 22 pathways included RhoA signaling in LPS, as well as histamine degradation, cholesterol 23 biosynthesis, FcγRIIB signaling, and others in HDE. Our results support previous research 24 indicating that pathways altered between baseline and treatment of PBMCs in horses with LPS or 25 HDE affect inflammatory responses through RhoA, B-cell signaling, IL-4 and IFN-γ, and histamine.
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102
The counting of and normalization of RNA molecules was done following Mason et al. (2018) 103 with minor changes [8] . We defined gene features with the NCBI annotation (release 103) of the horse 104 reference genome sequence EquCab3.0 (Assembly accession: GCF_002863925.1). We specified 105 desired features to be all transcripts of genes with the transcriptsBy() function in the Bioconductor R 106 library GenomicFeatures [19] . We counted the number of RNA reads that aligned to all transcripts of 107 each gene with the summarizeOverlaps() function in the Bioconductor R GenomicAlignments library 108 [19] . We simplified the count matrix to have one feature per gene, making genes (not transcripts of 109 genes) the RNAseq count feature. In the summarizeOverlaps function we specified 'mode = "Union", 110 singleEnd = FALSE, ignore.strand = TRUE, fragments = TRUE'. We counted each treatment 111 separately, and required genes to have at least one RNAseq read aligned to the gene in one 112 individual. We normalized read counts to make them comparable across individuals in DESeq2, and 113 then exported them to calculate a mean read count cutoff with the KS test statistic [8] . Genes with 114 mean normalized read counts below this mean count threshold removed from analysis for each 115 treatment separately. After trimming the number of genes, the gene expression raw counts were 116 again normalized and then variance stabilized with the varianceStabilizingTransformation() in
117
DESeq2 once for each treatment separately [20] . PCA plots of the variance stabilized gene counts were 118 generated with DESeq2 ( Fig S01) . No individuals were identified to have aberrant expression profiles 119 after analyzing the PCA plots, therefore no individuals were removed based upon expression profiles 120 ( Fig S01) 
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In equation two, y is the dependent variable representing the residuals of the trimmed, normalized, 153
and variance stabilized gene expression counts. In equation one, X is an incidence matrix for fixed 154 effects intercept, age, sex, Fam1, Fam2, disease status, SNP genotype (0, 1, or 2 for each individual: 0 155 is homozygous reference allele, 1 is heterozygous, and 2 is homozygous alternative allele), LPS
156
context, RCA context, and HDE context, β is the solution for the fixed effects intercept, age (in 157 years), sex, Fam1, Fam2, disease status, SNP genotype, LPS context, RCA context, and HDE context,
158
m is a vector of SNP marker genotypes, Y is an incidence matrix that identified which gene 159 expression values were present in which context (LPS, RCA, and HDE), u is the interaction effect 160 of m * Y , Z is an incidence matrix which identified the repeated gene expression measurements 161 (one from each context) for each individual, u is the vector of random individual effects, and ε is 162 the random residuals. 
170
We set the window size to include 200 SNPs, the variance threshold to 0.99, the cis distance to 500,000 171 (equivalent to 1Mb window), and considered results as significant if the adjusted p-value was < 0.05. 172 2.6. Pathway analysis 173 A core analysis in Ingenuity Pathway Analysis (IPA) v.01-13 was run on all genes from eQTLs 174 with significant interaction terms between baseline (MCK) and each of the three treatments of PBMCs 175 (LPS, RCA, and HDE) [13] . Results were considered significant if the p-value was less than 1e-2.
176
Results discussed are from the canonical pathway analysis. Gene names were mapped onto human, 177 mouse and rat. We required the relationship between molecules to be direct and experimentally (Tables S1-S4 ). We detected a significantly different 193 genotypic effect on gene expression between MCK and LPS, RCA, or HDE (a significant 194 SNPxTreatment interaction term) for 1,057, 938, and 1,847 genes respectively (Tables S5-S7 ). To be 195 kept for further analyses, we required each gene SNP pair with a significant interaction term (Tables 196 S5-S7) to also be a significant eQTL in 1) MCK, 2) a treatment (LPS, RCA, or HDE), or 3) both MCK 197 and treatment (Table 1 , & S1-S4). This reduced the list of eQTLs analyzed to 144 for LPS, 60 for RCA,
198
and 213 for HDE (Fig 2) . Biologically, these represent 1) eQTLs present in MCK but not present in a with opposing directions of effect (Fig 2) [12]. We report the number of eQTLs with significant 202 interaction terms present in each of the four scenarios (Table 1) .
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We found no eQTLs with opposing directions of effect when eQTLs were significant in both 204 MCK and a treatment (black data-points) (Fig 2, Table 1 ). All data points with opposing directions of 205 effect in figure 1 have one non-significant gene/SNP association in either MCK or a treatment (orange 206 or blue data-points). Therefore, we found no evidence that SNPs associated with significant changes 207 in gene expression between MCK and a treatment caused strong opposing regulatory effects. Rather, 208 the majority of eQTLs with a significant difference in gene expression regulation between contexts 209 resulted in either a complete loss of an eQTL, gain of an eQTL, or the eQTL was modified but 210 maintained the same direction of effect. 
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We discovered eQTLs associated with significant changes in gene expression regulation due to 235 treatment of PBMCs in European Warmblood horses to identify gene pathways affected by treatment 236 of LPS, RCA, or HDE. We removed variation in eQTLs correlated with age, sex, family structure, and 237 disease (SEA) status to discover changes in eQTLs due to antigen treatment. By adjusting for these 238 confounding factors, we focused our analysis on changes in gene expression regulation caused by 239 antigen treatments. We expected LPS to influence genes involved in inflammatory regulation because 240 it is present in the cell membrane of gram-negative bacteria, RCA to elicit an immune response as it 241 is an antigen released from parasitic cyathostomins, and HDE to elicit allergic and inflammatory 242 responses as HDE is derived from moldy hay. Therefore, we hypothesized that gene expression 243 regulation altered by PBMC treatment would affect pathways involved in inflammatory and allergic 244 immune responses. We detected significant canonical pathways for each treatment. However, the 245 results for RCA may not be robust as only one gene was present in significant pathways. Therefore,
246
we focused the discussion of significant canonical pathways on LPS and HDE treatments. induced secretion of . Therefore, we hypothesize that RhoA also plays a role in the 251 inflammatory response following PBMC stimulation with LPS in horses.
activated mast cells [27, 28] . Cholesterol biosynthesis was also influenced by HDE treatment. Dietary represented by values 0, 1, and 2 while LPS is 0 or 1. The three remaining figure sections represent
